CD8A and neoplasm: The effectiveness of anti-PD-1 therapy was shown in a study with tumor-infiltrating CD8 with high PD-1 expression treated with anti-PD-1 and anti-TIM3 and/or LAG3 therapy had restored hindered proliferation and cytokine production [32].